The effect of race on pathologic complete response rates and overall survival in patients with triple negative breast cancer

被引：0
|
作者：
Woriax, Hannah E.
Thomas, Samantha M.
Plichta, Jennifer K.
Rosenberger, Laura H.
van de Bruele, Astrid Botty
Chiba, Akiko
DiLalla, Gayle
Menendez, Carolyn
Hwang, E. Shelley
DiNome, Maggie L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P1-06-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-06-02
引用
收藏
页数：3
相关论文
共 50 条
  • [41] ERCC1 Expression and Complete Pathologic Response to Platinum-Based Therapy for Patients with Triple Negative Breast Cancer
    Cioffi-Lavina, M.
    Hurley, J.
    Walker, G.
    Hu, J. J.
    Jorda, M.
    Gomez-Fernandez, C.
    MODERN PATHOLOGY, 2012, 25 : 30A - 30A
  • [42] Pathologic Complete Response in Triple Negative Breast Cancer of Black vs White Patients in the Post-Keynote 522 Era
    Sheen, Melanie
    Chung, Victoria
    Maini, Ruby
    Duggan, Michael
    Levy, Julia
    CANCER RESEARCH, 2023, 83 (05)
  • [43] Association between lincRNA expression and overall survival for patients with triple-negative breast cancer
    Ping, Jie
    Huang, Shuya
    Wu, Jie
    Bao, Pingping
    Su, Timothy
    Gu, Kai
    Cai, Hui
    Guo, Xingyi
    Lipworth, Loren
    Blot, William J.
    Zheng, Wei
    Cai, Qiuyin
    Shu, Xiao-Ou
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 769 - 777
  • [44] Association between lincRNA expression and overall survival for patients with triple-negative breast cancer
    Jie Ping
    Shuya Huang
    Jie Wu
    Pingping Bao
    Timothy Su
    Kai Gu
    Hui Cai
    Xingyi Guo
    Loren Lipworth
    William J. Blot
    Wei Zheng
    Qiuyin Cai
    Xiao-Ou Shu
    Breast Cancer Research and Treatment, 2021, 186 : 769 - 777
  • [45] Pathologic complete response (pCR) to predict patients' survival in luminal breast cancer.
    Wang-Lopez, Qian
    Kwiatkowski, Fabrice
    Abrial, Catherine
    Mouret-Reynier, Marie-Ange
    Dubray-Longeras, Pascale
    Van Praagh-Doreau, Isabelle
    Radosevic-Robin, Nina
    Durando, Xavier
    Penault-Llorca, Frederique
    Chollet, Philippe J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] Triple Negative Breast Cancer Has Worse Overall Survival and Cause-Specific Survival Than Non-Triple Negative Breast Cancer
    Li, Xiaoxian
    Yang, Jing
    Peng, Limin
    Sahin, Aysegul A.
    Huo, Lei
    Ward, Kevin C.
    O'Regan, Ruth
    Torres, Mylin A.
    Meisel, Jane L.
    MODERN PATHOLOGY, 2017, 30 : 54A - 54A
  • [47] Triple Negative Breast Cancer Has Worse Overall Survival and Cause-Specific Survival Than Non-Triple Negative Breast Cancer
    Li, Xiaoxian
    Yang, Jing
    Peng, Limin
    Sahin, Aysegul A.
    Huo, Lei
    Ward, Kevin C.
    O'Regan, Ruth
    Torres, Mylin A.
    Meisel, Jane L.
    LABORATORY INVESTIGATION, 2017, 97 : 54A - 54A
  • [48] Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival
    Kern, Peter
    Kalisch, Anne
    von Minckwitz, Gunter
    Puetter, Carolin
    Kolberg, Hans-Christian
    Pott, Dirk
    Kurbacher, Christian
    Rezai, Mahdi
    Kimmig, Rainer
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (03) : 210 - 217
  • [49] Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Pathologic Complete Response and Survival after Long-Term Follow-Up
    Guiu, S.
    Arnould, L.
    Coudert, B.
    Liegard, M.
    Mayer, F.
    Favier, L.
    Fumoleau, P.
    CANCER RESEARCH, 2009, 69 (24) : 572S - 572S
  • [50] A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer
    Sean M. Hacking
    Gabrielle Windsor
    Robert Cooper
    Zhicheng Jiao
    Ana Lourenco
    Yihong Wang
    Breast Cancer, 2024, 31 : 529 - 535
12345